Filing Details
- Accession Number:
- 0001325812-14-000022
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-04 17:51:40
- Reporting Period:
- 2014-02-03
- Filing Date:
- 2014-02-04
- Accepted Time:
- 2014-02-04 17:51:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1178670 | Alnylam Pharmaceuticals Inc. | ALNY | Pharmaceutical Preparations (2834) | 770602661 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1514291 | Michael Mason | 300 Third Street Cambridge MA 02142 | Vp, Finance And Treasurer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-02-03 | 1,540 | $78.08 | 3,747 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-03 | 2,110 | $79.04 | 1,637 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-03 | 100 | $79.74 | 1,537 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,906 | Indirect | by Managed Account |
Footnotes
- The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2012.
- Sale prices ranged from $77.52 to $78.51.
- Sale prices ranged from $78.55 to $79.36.
- The reporting person owns 1,906 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.